Cocaine, pregnancy, and the neonate

Area of Science:

• Perinatal Medicine
• Neonatal Studies
• Substance Abuse Research

Background:

• Increasing prevalence of cocaine use among women of childbearing age in the U.S.
• Cocaine use during pregnancy poses significant risks to maternal and infant health.
• Need for comprehensive understanding of cocaine's impact on pregnancy and neonatal outcomes.

Purpose of the Study:

• To evaluate pregnancy and neonatal outcomes in infants born to cocaine-using women.
• To compare outcomes with a drug-free control group matched for social and demographic factors.
• To identify specific complications associated with maternal cocaine abuse.

Main Methods:

• Prospective study evaluating 70 infants born to cocaine-using women at the Perinatal Center for Chemical Dependence.
• Comparison with a matched group of drug-free controls.
• Assessment of pregnancy complications and neonatal outcomes.

Main Results:

• Cocaine-addicted women experienced a high incidence of pregnancy complications.
• Infants born to cocaine-using mothers showed increased rates of intrauterine growth retardation.
• Higher rates of prematurity, microcephaly, and perinatal morbidity were observed in cocaine-exposed infants.

Conclusions:

• Maternal cocaine use is associated with significant adverse pregnancy and neonatal outcomes.
• Cocaine-exposed infants are at increased risk for medical and developmental disabilities.
• Future research should explore polydrug use, maternal-infant interaction, and environmental factors.